Marvin 06201313222D 9 9 0 0 1 0 999 V2000 10.1226 -7.7863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.7901 -8.2712 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 10.3775 -7.0016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.2025 -7.0016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.2421 -8.0412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.8553 -7.4890 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 12.4137 -8.8482 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 9.3380 -8.0413 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 11.4575 -7.7862 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 2 1 1 0 0 0 0 3 1 1 0 0 0 0 9 2 1 0 0 0 0 4 3 1 0 0 0 0 4 9 1 0 0 0 0 6 5 2 0 0 0 0 7 5 1 0 0 0 0 9 5 1 1 0 0 0 8 1 2 0 0 0 0 M END > CHEBI:18183 > 5-oxo-L-proline > An optically active form of 5-oxoproline having L-configuration. > 3 > CHEBI:44704; CHEBI:2113; CHEBI:12153; CHEBI:20619 > PYROGLUTAMIC ACID; Pyroglutamic acid; Pyroglutamate; pidolic acid; L-Pyroglutamic acid; L-5-Pyrrolidone-2-carboxylic acid; 5-Pyrrolidone-2-carboxylic acid; 5-Oxo-L-proline; 5-Oxo-L-proline; (S)-pyroglutamic acid; (S)-(-)-2-pyrrolidone-5-carboxylic acid; (-)-2-pyrrolidone-5-carboxylic acid > 5-oxo-L-proline; (2S)-5-oxopyrrolidine-2-carboxylic acid > C5H7NO3 > 129.11400 > 129.04259 > 0 > OC(=O)[C@@H]1CCC(=O)N1 > InChI=1S/C5H7NO3/c7-4-2-1-3(6-4)5(8)9/h3H,1-2H2,(H,6,7)(H,8,9)/t3-/m0/s1 > ODHCTXKNWHHXJC-VKHMYHEASA-N > 82132 > 98-79-3 > 1125330 > 82132 > 98-79-3 > DB03088 > C01879 > C00007403 > 5-OXOPROLINE > 98-79-3 > PCA > Pyroglutamic_acid > YMDB00107 > 17439666; 22560249; 22619187 $$$$